文献速递胸部外周血管CTMRDSA

对肺栓塞诊断前瞻性研究(PIOPED)II和III数据的临床意义解读

A Clinically Meaningful Interpretation of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II and III Data.
PubMed 文献 · Acad Radiol · 2018-01-11

该研究基于PIOPED II和III数据,计算MDCTPA±CTV与MRPA±MRV在九种临床预测规则各概率层级下的多级似然比和验后概率;阳性似然比MRPA高于MDCTPA,但两者均>10可确认肺栓塞;静脉成像降低阳性和阴性似然比,并给出列线图。

要点

  • 阳性似然比MRPA高于MDCTPA(无静脉成像76 vs 20,有静脉成像42 vs 18)。
  • 阴性似然比MDCTPA低于MRPA(无静脉成像0.18 vs 0.22,有静脉成像0.12 vs 0.15)。
  • 阳性MRPA和MDCTPA的似然比均>10,可确认肺栓塞存在。

核心结论

  • 阳性结果时,MRPA的似然比 considerably 高于MDCTPA,但两者阳性似然比均>10,可确认肺栓塞存在。
  • 进行静脉成像降低了MDCTPA和MRPA阳性和阴性结果的似然比。
  • 列线图给出了每种临床预测规则各临床概率层级下MDCTPA和MRPA(含或不含静脉成像)阳性、不确定和阴性结果的验后概率。

研究设计与样本

  • 研究设计为观察性研究的综述,并对多项队列研究进行批判性审查。
  • 数据用于估算九种最常用临床预测规则(Wells、Geneva、Miniati和Charlotte)各概率层级的肺栓塞验前概率。
  • 从PIOPED II和PIOPED III的敏感度和特异度结果生成多级似然比(阳性、不确定、阴性),并计算MDCTPA、MDCTPA+CTV、MRPA和MRPA+MRV的验后概率。
  • 设置包括急性护理、急诊护理和门诊护理(住院和门诊患者)。

诊断标准与关键数值

  • 阳性似然比:MRPA无静脉成像76 vs MDCTPA无静脉成像20;MRPA有静脉成像42 vs MDCTPA有静脉成像18。
  • 阴性似然比:MDCTPA无静脉成像0.18 vs MRPA无静脉成像0.22;MDCTPA有静脉成像0.12 vs MRPA有静脉成像0.15。
  • 三级Wells评分低、中、高临床概率的肺栓塞验前概率分别为5.7、23和49。
  • 初始低临床概率时,MDCTPA阳性、不确定、阴性验后概率分别为54、5和1;MDCTPA+CTV分别为52、2和0.7;MRPA分别为82、6和1;MRPA+MRV分别为72、3和1。
  • 初始中等临床概率时,MDCTPA阳性、不确定、阴性验后概率分别为86、22和5;MDCTPA+CTV分别为85、10和4;MRPA分别为96、25和6;MRPA+MRV分别为93、14和4。

临床应用与阅片要点

  • 阳性MRPA和MDCTPA的似然比均>10,可确认肺栓塞存在。
  • 进行静脉成像降低了MDCTPA和MRPA阳性和阴性结果的似然比。
  • 列线图可用于每种临床预测规则各临床概率层级下MDCTPA和MRPA(含或不含静脉成像)阳性、不确定和阴性结果的验后概率估算。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aimed to calculate the multiple-level likelihood ratios (LRs) and posttest probabilities for a positive, indeterminate, or negative test result for multidetector computed tomography pulmonary angiography (MDCTPA) ± computed tomography venography (CTV) and magnetic resonance pulmonary angiography (MRPA) ± magnetic resonance venography (MRV) for each clinical probability level (two-, three-, and four-level) for the nine most commonly used clinical prediction rules (CPRs) (Wells, Geneva, Miniati, and Charlotte). The study design is a review of observational studies with critical review of multiple cohort studies. The settings are acute care, emergency room care, and ambulatory care (inpatients and outpatients).

MATERIALS AND METHODS: Data were used to estimate pulmonary embolism (PE) pretest probability for each of the most commonly used CPRs at each probability level. Multiple-level LRs (positive, indeterminate, negative test) were generated and used to calculate posttest probabilities for MDCTPA, MDCTPA + CTV, MRPA, and MRPA + MRV from sensitivity and specificity results from Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II and PIOPED III for each clinical probability level for each CPR. Nomograms were also created.

RESULTS: The LRs for a positive test result were higher for MRPA compared to MDCTPA without venography (76 vs 20) and with venography (42 vs 18). LRs for a negative test result were lower for MDCTPA compared to MRPA without venography (0.18 vs 0.22) and with venography (0.12 vs 0.15). In the three-level Wells score, the pretest clinical probability of PE for a low, moderate, and high clinical probability score is 5.7, 23, and 49. The posttest probability for an initially low clinical probability PE for a positive, indeterminate, and negative test result, respectively, for MDCTPA is 54, 5 and 1; for MDCTPA + CTV is 52, 2, and 0.7; for MRPA is 82, 6, and 1; and for MRPA + MRV is 72, 3, and 1; for an initially moderate clinical probability PE for MDCTPA is 86, 22, and 5; for MDCTPA + CTV is 85, 10, and 4; for MRPA is 96, 25, and 6; and for MRPA + MRV is 93, 14, and 4; and for an initially high clinical probability of PE for MDCTPA is 95, 47, and 15; for MDCTPA + CTV is 95, 27, and 10; for MRPA is 99, 52, and 17; and for MRPA + MRV is 98, 34, and 13.

CONCLUSIONS: For a positive test result, LRs were considerably higher for MRPA compared to MDCTPA. However, both a positive MRPA and MDCTPA have LRs >10 and therefore can confirm the presence of PE. Performing venography reduced the LR for a positive and negative test for both MDCTPA and MRPA. The nomograms give posttest probabilities for a positive, indeterminate, or negative test result for MDCTPA and MRPA (with and without venography) for each clinical probability level for each of the CPR.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Cronin P, Dwamena BA. A Clinically Meaningful Interpretation of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II and III Data. Acad Radiol. 2018. PMID: 29337091. doi:10.1016/j.acra.2017.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。